ReviewFrontiers in cardiovascular medicine2026
A systematic review and meta-analysis of the efficacy of addition and reduction of Shixiao powder in the treatment of coronary heart disease.
Review in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To evaluate the effectiveness and safety of combining Shixiao Powder with Western medicine for treating coronary heart disease-induced angina. Methods: The databases CNKI, VIP, Wanfang, SinoMed, PubMed, Embase, Web of Science, and Cochrane were searched until March 19th, 2024 for randomized controlled studies on the treatment of angina pectoris in coronary heart disease using Shixiao Powder combined with Western medicine. Quality assessment was conducted using the Cochrane Collaboration's tool. Heterogeneity was tested using the Chi-squared-based Q statistic test and I2 statistic. Results: The study included a total of 15 articles, with 1204 patients in the cohort, divided into 625 cases in the observation group and 579 cases in the control group. Compared to Western medicine alone, the combination of Shixiao powder and Western medicine significantly improved the effective rate in treating angina pectoris of coronary heart disease [RR = 1.25, 95%Cl (1.18-1.32), Conclusion: The current evidence supports that combining Shixiao Powder with Western medicine effectively and safely treats angina pectoris associated with coronary heart disease. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/recorddashboard, PROSPERO CRD42024537794.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.